A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer

J Cancer Immunol (Wilmington). 2024;6(4):148-153. doi: 10.33696/cancerimmunol.6.095.
No abstract available

Publication types

  • Comment